Corpus Intelligence IC Memo — SWEETWATER HOSPITAL ASSOCIATION 2026-04-26 15:53 UTC
IC Memo — SWEETWATER HOSPITAL ASSOCIATION
Investment Committee Memorandum | TN | 55 beds | Grade C | EBITDA uplift $4.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SWEETWATER HOSPITAL ASSOCIATION

CCN 440084 | MONROE, TN | 55 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SWEETWATER HOSPITAL ASSOCIATION is a 55-bed suburban community hospital in MONROE, TN with $56.6M in net patient revenue and a -10.8% operating margin. The hospital serves a payer mix of 25.6% Medicare, 16.1% Medicaid, and 58.3% commercial.

Thesis: Turnaround. Our ML models identify $4.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.8% to -3.4% (+736bps).

Net Revenue HCRIS$56.6M
Current EBITDA COMPUTED$-6.1M
Operating Margin COMPUTED-10.8%
Occupancy HCRIS66.7%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS20.9%
Distress Probability ML46.3%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
61
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -10.8% places it below the state median. Among 61 size-comparable peers (28-110 beds), the median margin is 0.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (28-110), prioritizing same-state peers. 61 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SWEETWATER HOSPITAL ASSOCIATIO (Target)TN55$56.6M-10.8%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SOUTHERN HILLS MEDICAL CENTERTN101$145.2M16.4%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HORIZON MEDICAL CENTERTN96$141.3M15.3%
MORRISTOWN-HAMBLEN HOSPITALTN102$126.6M11.8%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
FRANKLIN WOODS COMMUNITY HOSPITN80$110.3M18.7%
GREENEVILLE COMMUNITY HOSPITALTN81$104.5M-5.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$689K+122bp9mo
Clean Claim Rate88.0%96.0%$36K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$689K
Clean Claim Rate
$36K
Total EBITDA Uplift$4.2M
Current EBITDA$-6.1M
+ RCM Uplift+$4.2M
Pro Forma EBITDA$-1.9M
Current Margin-10.8%
Pro Forma Margin-3.4%
WC Released (1x)$2.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.4M$1.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.4M$-1.6M0.00x-100.0%
Bull Case9.0x11.0x$-8.5M$9.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.5M$7.4M0.00x-100.0%
Bear Case11.0x10.0x$-10.3M$-16.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.3M$-21.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 61 hospitals with 28-110 beds
  • Same-state prioritization (n=62)
  • Comp margins: P25=-11.7% / P50=0.6% / P75=11.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.